Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

• Status: Recruiting
• Trial end date: 2023-08-15
• Target enrollment: 0
• Participant gender: All

Summary

Suprachoroidal drug delivery is a recent route for managing various ocular conditions. Safety and long term results are still under investigations.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• cases with central macular thickness more than 250 microns measured by optical coherence tomography due to one of the following conditions:

• Diabetic macular edema

• Vogt-koyanagi Harada disease

• Retinal vein occlusion.

Exclusion Criteria:

• other causes of increased macular thickness as age related macular degeneration and myopic choroidal new vascularization.

• Cases with confirmed diagnosis of glaucoma.